,Name_VH,Name_VL,Genbank_protein_id_vh,Genbank_protein_id_vl,Binds_to,Origin,VH,VL,Reference,Description_VH,Description_VL,Date_added
0,NaN,NaN,S42399,NaN,not determined,Homo sapiens (human),QVQLVQSGAEVKKPGASVKVSCKASGYTFAMYAIHWVRQAPGQSLEWMGWISVADGKTKYSQKFQDRVTITRDTSATTAYMEVRGLRSEDTAVYYCAR,NaN,"Chouchane,L. et al.; Molecular characterization of a human anti-Rh(D) antibody with a DH segment encoded by a germ-line sequence; Eur. J. Biochem. 207 (3), 1115-1121 (1992); 1993.","IgVH Rh D [human, mRNA Partial, 296 nt]",NaN,2022-03-14
1,ANTI-HUMAN,NaN,E14571,NaN,not determined,Mus musculus (house mouse),MGWSWIFLFLLSGTAGVHSEVQLQQSGPELVKPGASVKISCKASGYTFTDYNMHWVKQSHGKSLEWIGYIYPYNGGTGYNQKFKSKATLTVDNSSSTAYMELRSLTSEDSAVYYCARSYYAMDYWGQGTSVTVSSESQSFPNVFPLVSCESPLSDKNLVAMGCLARDFLPSTISFTWNYQNNTEVIQGIRTFPTLRTGGKYLATSQVLLSPKSILEGSDEYLVCKIHYGGKNRDLHVPIPAVAEMNPNVNVFVPPRDGFSGPAPRKSKLICEATNFTPKPITVSWLKDGKLVESGFTTDPVTIENKGSTPQTYKVISTLTISEIDWLNLNVYTCRVDHRGLTFLKNVSSTCAASPSTDILTFTIPPSFADIFLSKSANLTCLVSNLATYETLNISWASQSGEPLETKIKIMESHPNGTFSAKGVASVCVEDWNNRKEFVCTVTHRDLPSPQKKFISKPNEVHKHPPAVYLLPPAREQLNLRESATVTCLVKGFSPADISVQWLQRGQLLPQEKYVTSAPMPEPGAPGFYFTHSILTVTEEEWNSGETYTCVVGHEALPHLVTERTVDKSTGKPTLYNVSLIMSDTGGTCY*,NaN,"Serizawa,N. et al.; DNA CODING VARIABLE REGION OF MONOCLONAL ANTIBODY, AND RECOMBINED ANTIBODY; JP1997322796-A 1 16-DEC-1997 SANKYO CO LTD; 1999.",Mouse mRNA for immunoglobulin heavy chain of anti-human Fas mouse monoclonal antibody CH11,NaN,2022-03-14
2,NaN,NaN,MZ927184,NaN,SARS-CoV-2,synthetic construct,QVQLVQSGAEVKKPGASVKVSCKVSGYTSPATIHWVRQAPGKGLEWMGGISPYKGDTIYAQKFQGRVTMTEDTSTDTAYMELSSLKSEDTAVYYCAKDSYYYDSSGSGLGGGFDYWGQGTLVTVSS,NaN,"Ferrara,F. et al.; The unique antibody discovery competition triggered by COVID-19: a naive library directly delivering antibodies as potent as immune sources; Unpublished; 2021.","Synthetic construct clone 41 immunoglobulin heavy chain variable region gene, partial cds",NaN,2022-03-14
3,NaN,NaN,NaN,MZ927183,SARS-CoV-2,synthetic construct,NaN,DIQMTQSPSSVSASVGDRVTITCRASRDISSYLAWYQQKPGKAPKLLIYGASTRASGVPSRFSGSGSGTDFTLTISSLQPEDFANYYCLQYSIYPWTFGGGTKVEIK,"Ferrara,F. et al.; The unique antibody discovery competition triggered by COVID-19: a naive library directly delivering antibodies as potent as immune sources; Unpublished; 2021.",NaN,"Synthetic construct clone 41 immunoglobulin light chain variable region gene, partial cds",2022-03-14
4,H.SAPIENS,NaN,Z14302,NaN,not determined,Homo sapiens (human),*GAS*S*G*GRDPGLVKEDFIHPCVLSTGVQSQVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYAISWVRQAPGQGLEWMGGIIPIFGTANYAQKFQGRVTITADKSTSTAYMELSSLRSEDTAVYYCAR,NaN,"Sasso,E.H. et al.; A fetally expressed immunoglobulin VH1 gene belongs to a complex set of alleles; J. Clin. Invest. 91 (6), 2358-2367 (1993); 1992.",H.sapiens gene for immunoglobulin heavy chain variable region (VH1),NaN,2022-03-14
5,FLJ41806,NaN,AK123800,NaN,not determined,Homo sapiens (human),N*IPPL*QPLGAQLFTMDWTWRFLFVVAAAAGVQSLLQLVQSGAEVKKPGSSVTVSCEASGDSSPTYTISWVRQAPGQGLEWMGDITPVFGTKEMSQKFQDRVSITADSVSVTADTRRTVYLEVRRLTSDDSAVYYCAKSETDHSFYYYIELWGQGTTVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSRDELTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPGK*VRRPASPRSPGSRGRARMLGTYPVYILPGRPAWK*STQRCPGPL,NaN,"Suzuki,O. et al.; NEDO human cDNA sequencing project; Unpublished; 2003.","Homo sapiens cDNA FLJ41806 fis, clone NOVAR2001108, highly similar to Human (hybridoma H210) anti-hepatitis A IgG variable region, constant region, complementarity-determining regions mRNA, complete cds",NaN,2022-03-14
6,ANTI-HUMAN,NaN,E13088,NaN,not determined,Mus sp.,VQLQESGAEPAKPGASVKMSCKASGYTFTTYWMHWVKQRPGQGLEWIGYINPSSGYTEYNQKFKDKATLTADKSSSTAYMQLISLTSEDSAVYYCARRGNYYYFDYWGQGTTVTVSS,NaN,"Kiyono,K. et al.; THERAPEUTIC AGENT FOR HEPATITIS; JP1997124509-A 8 13-MAY-1997 SUMITOMO ELECTRIC IND LTD; 1998.",cDNA encoding variable region of H chain of anti-human Fas ligand antibody which hybridoma NOK5 produces,NaN,2022-03-14
7,ANTI-HUMAN,NaN,E12189,NaN,not determined,Homo sapiens (human),QVQLQESGPGLVKPSGTLSLTCAVSGGSISSSNWWSWVRQPPGKGLEWIGEIYHSGSTNYNPSLKSRVTISADTSKNQFSLKVNSVTAADTAVYYCARRNYDFWSGGDGPFDYWGQGTLVTVSS,NaN,"Murakami,H. et al.; ANTIBODY AND ANTIBODY CDNA; JP1996280386-A 1 29-OCT-1996 MORINAGA & CO LTD; 1998.",DNA encoding variable region of heavy chain of human anti-human pulmonary carcinoma antibody,NaN,2022-03-14
8,NaN,NaN,E13412,NaN,not determined,unidentified,MAKVKLQESGAELVRPGSSVKISCKASGYVFSSYWMNWVKQRPGQGLEWIGQINPGDGDTNYNGKFKGKVTLTADKSSSTAHMQLSSLTSEDSAVYFCTRMGVRRDYWGQGTTVTVSSGGGGSGGGGSGGGGSDIELTQSPAIMSASLGERVTMTCTASSSVSSSNLHWYQQKSETSPKPWIYGTSNLASGIPVRFSGSGSGTSYSLTISSMEGEDAATYYCQQWSSNPFTFGSGTKLEIKGGLENDENIVYGPEPFYPIEEGSAGAQLRKYMDRYAKLGAIAFTNALTGVDYTYAEYLEKSCCLGEALKNYGLVVDGRIALCSENCEEFFIPVLAGLFIGVGVAPTNEIYTLRELVHSLGISKPTIVFSSKKGLDKVITVQKTVTAIKTIVILDSKVDYRGYQSMDNFIKKNTPQGFKGSSFKTVEVNRKEQVALIMNSSGSTGLPKGVQLTHENLVTRFSHARDPIYGNQVSPGTAILTVVPFHHGFGMFTTLGYLTCGFRIVMLTKFDEETFLKTLQDYKCSSVILVPTLFAILNRSELLDKYDLSNLVEIASGGAPLSKEIGEAVARRFNLPGVRQGYGLTETTSAIIITPEGDDKPGASGKVVPLFKAKVIDLDTKKTLGPNRRGEVCVKGPMLMKGYVDNPEATREIIDEEGWLHTGDIGYYDEEKHFFIVDRLKSLIKYKGYQVPPAELESVLLQHPNIFDAGVAGVPDPIAGELPGAVVVLEKGKSMTEKEVMDYVASQVSNAKRLRGGVRFVDEVPKGLTGKIDGKAIREILKKPVAKM,NaN,"Masuda,S. et al.; ANTIBODY-FIREFLY LUCIFERASE FUSION PROTEIN, GENE OBTAINED THEREFROM, NOVEL RECOMBINANT DNA AND PRODUCTION OF ANTIBODY-FIREFLY LUCIFERASE FUSION PROTEIN; JP1997187281-A 3 22-JUL-1997 KIKKOMAN CORP; 1998.",cDNA encoding fused protein consisted of antibody and firefly luciferase,NaN,2022-03-14
9,15G9,NaN,MZ751046,NaN,"SARS-CoV-2, Spike protein RBD",Mus musculus (house mouse),VQLQQSGPEVVRPGVSVKISCKGSGYTFTDYAIHWVKQSHAKSLEWIGVISSHNGNRGYNQKFKGMATVTVDRSSSTAYMELARLTSEDSAIYYCAIFDYDFDYWGQGTTVMVSS,NaN,"Zhang,G. et al.; Epitope profiling reveals the critical antigenic determinants in SARS-CoV-2 RBD-based antigen; Unpublished; 2021.","Mus musculus clone 15G9 anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region mRNA, partial cds",NaN,2022-03-14
10,10D2,NaN,MZ751049,NaN,"SARS-CoV-2, Spike protein RBD",Mus musculus (house mouse),VQLQQSGPELKKPGETVKISCKASGYTFTKYRMHWVKQAPGKGLKWMGWINTNTGESTYADDFKGRFAFSLETSASTAYLQINNLKNEDTATYFCASSMDYWGQGTTVTVSS,NaN,"Zhang,G. et al.; Epitope profiling reveals the critical antigenic determinants in SARSCoV-2 RBD-based antigen; Unpublished; 2021.","Mus musculus clone 10D2 anti-SARS-CoV-2 spike protein immunoglobulin heavy chain variable region mRNA, partial cds",NaN,2022-03-14
11,NaN,15G9/10D2,NaN,MZ751050,"SARS-CoV-2, Spike protein RBD",Mus musculus (house mouse),NaN,DIVLTQSPASLAVSLGQRATISYRASKSVSTSGYSYMHWNQQKPGQPPRLLIYLVSNLESGVPARFSGSGSGTDFTLNIHPVEEEDAATYYCQHIRELTRSEGGPSW,"Zhang,G. et al.; Epitope profiling reveals the critical antigenic determinants in SARSCoV-2 RBD-based antigen; Unpublished; 2021.",NaN,"Mus musculus clone 15G9/10D2 anti-SARS-CoV-2 spike protein immunoglobulin light chain variable region mRNA, partial cds",2022-03-14
12,NaN,CA1,NaN,MT470194,SARS-CoV-2,Homo sapiens (human),NaN,DIVMTQTPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRRNWGTFGPGTKVDIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGECS*,"Shi,R. et al.; A potent human neutralizing monoclonal antibody targeting the receptor binding site of SARS-CoV-2 virus; Unpublished; 2020.",NaN,"Homo sapiens clone CA1 anti-SARS-CoV-2 immunoglobulin light chain variable region mRNA, partial cds",2022-03-14
13,NaN,L-CHAIN,NaN,E01737,not determined,Homo sapiens (human),NaN,DIVMTQSPDSLAVSLGERATINCKSSQSVLYSSNNKNYLAWYQQKPRQPPKLLIYWASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQYYSTPRTFGQGTKVEIK,"Nakatani,T. et al.; HUMAN ANTIBODY, ANTIBODY GENE AND CORRESPONDING RECOMBINANT; JP1988267295-A 6 04-NOV-1988 SUMITOMO CHEM CO LTD, SUMITOMO PHARMACEUT CO LTD; 1997.",NaN,Genomic DNA encoding V region of L-chain of monoclonal antibody against pseudomonas aeruginosa exotoxin,2022-03-14
14,P5A-1D2HC,NaN,MZ151910,NaN,SARS-CoV-2,Homo sapiens (human),EVQLVESGGGLIQPGGSLRLSCAASGFIVSSNYMSWVRQAPGKGLEWVSIIYSGGSTYYADSVKGRFTISRDNSNNTLYLQMNSLRAEDTAVYYCARALQVGATSDYFDYWGQGTLVTVSS,NaN,"Ju,B. et al.; Direct Submission; Submitted (06-MAY-2021) Institute for Hepatology, Shenzhen Third People Hospital, Bulan, Shenzhen 518112, China; 2021.","Homo sapiens isolate P5A-1D2HC anti-SARS-CoV-2 immunoglobulin heavy chain variable region mRNA, partial cds",NaN,2022-03-14
15,P5A-3C8HC,NaN,MZ151912,NaN,SARS-CoV-2,Homo sapiens (human),EVQLVESGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSFIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDLQEHGMDVWGQGTTVTVSS,NaN,"Ju,B. et al.; Direct Submission; Submitted (06-MAY-2021) Institute for Hepatology, Shenzhen Third People Hospital, Bulan, Shenzhen 518112, China; 2021.","Homo sapiens isolate P5A-3C8HC anti-SARS-CoV-2 immunoglobulin heavy chain variable region mRNA, partial cds",NaN,2022-03-14
16,P22A-1D1HC,NaN,MZ151914,NaN,SARS-CoV-2,Homo sapiens (human),EVQLVESGGGLIQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDRDYYGMDVWGQGTTVTVSS,NaN,"Ju,B. et al.; Direct Submission; Submitted (06-MAY-2021) Institute for Hepatology, Shenzhen Third People Hospital, Bulan, Shenzhen 518112, China; 2021.","Homo sapiens isolate P22A-1D1HC anti-SARS-CoV-2 immunoglobulin heavy chain variable region mRNA, partial cds",NaN,2022-03-14
17,P2B-2F6HC,NaN,MW259136,NaN,SARS-CoV-2,Homo sapiens (human),QVQLQESGPGLVKPSETLSLTCTVSGYSISSGYYWGWIRQPPGKGLEWIGSIYHSGSTYYNPSLKTRVTISVDTSKNQFSLKLSSVTAADTAVYYCARAVVGIVVVPAAGRRAFDIWGQGTMVTVSS,NaN,"Ju,B. et al.; Direct Submission; Submitted (13-NOV-2020) Institute for Hepatology, Shenzhen Third People Hospital, Bulan, Shenzhen 518112, China; 2020.","Homo sapiens isolate P2B-2F6HC anti-SARS-CoV-2 immunoglobulin heavy chain variable region mRNA, partial cds",NaN,2022-03-14
18,P2C-1F11HC,NaN,MW259138,NaN,SARS-CoV-2,Homo sapiens (human),EVQLVESGGGLVQPGGSLRLSCAASGITVSSNYMNWVRQAPGKGLEWVSLIYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYHCARDLVVYGMDVWGQGTTVTVSS,NaN,"Ju,B. et al.; Direct Submission; Submitted (13-NOV-2020) Institute for Hepatology, Shenzhen Third People Hospital, Bulan, Shenzhen 518112, China; 2020.","Homo sapiens isolate P2C-1F11HC anti-SARS-CoV-2 immunoglobulin heavy chain variable region mRNA, partial cds",NaN,2022-03-14
19,P2C-1A3HC,NaN,MW259140,NaN,SARS-CoV-2,Homo sapiens (human),QVQLVESGGGLVKPGGSLRLSCAASGFTFSDYYMSWIRQAPGKGLEWVSYISSSGSTIYYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARDFSHQQLVPSWGQGTLVTVSS,NaN,"Ju,B. et al.; Direct Submission; Submitted (13-NOV-2020) Institute for Hepatology, Shenzhen Third People Hospital, Bulan, Shenzhen 518112, China; 2020.","Homo sapiens isolate P2C-1A3HC anti-SARS-CoV-2 immunoglobulin heavy chain variable region mRNA, partial cds",NaN,2022-03-14
20,NaN,P5A-1D2LC,NaN,MZ151911,SARS-CoV-2,Homo sapiens (human),NaN,QSVLTQPPSVSGAPGQRVTISCTGSSSNIGAGYDVHWYQQLPGTAPKLLIYGNSNRPSGVPDRFSGSKSGTSASLAITGLQAEDETDYYCQSCDSSLSVVVFGGGTKLTVL,"Ju,B. et al.; Direct Submission; Submitted (06-MAY-2021) Institute for Hepatology, Shenzhen Third People Hospital, Bulan, Shenzhen 518112, China; 2021.",NaN,"Homo sapiens isolate P5A-1D2LC anti-SARS-CoV-2 immunoglobulin light chain variable region mRNA, partial cds",2022-03-14
21,NaN,P5A-3C8KC,NaN,MZ151913,SARS-CoV-2,Homo sapiens (human),NaN,DIQLTQSPSSLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQHLNSYPPGYTFGQGTKLEIK,"Ju,B. et al.; Direct Submission; Submitted (06-MAY-2021) Institute for Hepatology, Shenzhen Third People Hospital, Bulan, Shenzhen 518112, China; 2021.",NaN,"Homo sapiens isolate P5A-3C8KC anti-SARS-CoV-2 immunoglobulin light chain variable region mRNA, partial cds",2022-03-14
22,NaN,P22A-1D1KC,NaN,MZ151915,SARS-CoV-2,Homo sapiens (human),NaN,DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCLHLNSYRTFGLGTKVEIK,"Ju,B. et al.; Direct Submission; Submitted (06-MAY-2021) Institute for Hepatology, Shenzhen Third People Hospital, Bulan, Shenzhen 518112, China; 2021.",NaN,"Homo sapiens isolate P22A-1D1KC anti-SARS-CoV-2 immunoglobulin light chain variable region mRNA, partial cds",2022-03-14
23,NaN,P2B-2F6LC,NaN,MW259137,SARS-CoV-2,Homo sapiens (human),NaN,QSALTQPPSASGSPGQSVTISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYEVSKRPSGVPDRFSGSKSGNTASLTVSGLQAEDEADYYCSSYAGSNNLVFGGGTKLTVL,"Ju,B. et al.; Direct Submission; Submitted (13-NOV-2020) Institute for Hepatology, Shenzhen Third People Hospital, Bulan, Shenzhen 518112, China; 2020.",NaN,"Homo sapiens isolate P2B-2F6LC anti-SARS-CoV-2 immunoglobulin light chain variable region mRNA, partial cds",2022-03-14
24,NaN,P2C-1F11KC,NaN,MW259139,SARS-CoV-2,Homo sapiens (human),NaN,EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPTFGQGTKLEIK,"Ju,B. et al.; Direct Submission; Submitted (13-NOV-2020) Institute for Hepatology, Shenzhen Third People Hospital, Bulan, Shenzhen 518112, China; 2020.",NaN,"Homo sapiens isolate P2C-1F11KC anti-SARS-CoV-2 immunoglobulin light chain variable region mRNA, partial cds",2022-03-14
25,NaN,P2C-1A3KC,NaN,MW259141,SARS-CoV-2,Homo sapiens (human),NaN,DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNSYPLTFGGGTKVEIK,"Ju,B. et al.; Direct Submission; Submitted (13-NOV-2020) Institute for Hepatology, Shenzhen Third People Hospital, Bulan, Shenzhen 518112, China; 2020.",NaN,"Homo sapiens isolate P2C-1A3KC anti-SARS-CoV-2 immunoglobulin light chain variable region mRNA, partial cds",2022-03-14
26,F4,NaN,E01610,NaN,not determined,Homo sapiens (human),EVQLLESGGGLVQPGGSLRLSCTASGFTFSTYAMSWVRQTPGKGLHWVSAISGSDTGTYHAESVRGRLTISRDNSKNTLYLQMNNLRVEDTALYFCAK,NaN,"Hozumi,T. et al.; DNA CODING H-CHAIN OF ANTIPYOCYANIC HUMAN-TYPE ANTIBODY; JP1988152983-A 1 25-JUN-1988 WAKUNAGA PHARMACEUT CO LTD; 1997.",DNA encoding variable region H chain of anti pseudomonas aeruginosa (F4 type) antibody,NaN,2022-03-14
27,368.07.28.GC.1A11.HC,NaN,MW926396,NaN,SARS-CoV-2,Homo sapiens (human),EVQLVESGGGLVKPGGSLRLSCAASGFTFSYAWMTWVRQAPGKGLEWVGRIKSKTDGGTTDYAAPVKGRFTISRDDSKNTLFLQMNSLKTEDTAVYFCTTGWFTGTYGDYFDYWGQGTLVTVSS,NaN,"Turner,J.S. et al.; SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses; Nature 596 (7870), 109-113 (2021); 2021.","Homo sapiens isolate 368.07.28.GC.1A11.HC immunoglobulin variable region heavy chain mRNA, partial cds",NaN,2022-03-14
28,368.20.28.GC.3C08.HC,NaN,MW926407,NaN,SARS-CoV-2,Homo sapiens (human),EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYWMSWVRQAPGKGLEWVANIKEDGSEKYYVDSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCAREGTYYYDSSAYYNGGLDYWGQGTLVTVSS,NaN,"Turner,J.S. et al.; SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses; Nature 596 (7870), 109-113 (2021); 2021.","Homo sapiens isolate 368.20.28.GC.3C08.HC immunoglobulin variable region heavy chain mRNA, partial cds",NaN,2022-03-14
29,368.22.28.GC.1B08.HC,NaN,MW926409,NaN,SARS-CoV-2,Homo sapiens (human),EVQLVQSGAEAKKPGASVNISCRTSGYTFSNYYIHWVRQAPGQGLEWMGIFNPSGGGTSYAQNFQGRLTMTSDTSTSTVFMELSSLGSEDTAVYYCARDPRVPAVTNVNDAFDLWGQGTMVTVSS,NaN,"Turner,J.S. et al.; SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses; Nature 596 (7870), 109-113 (2021); 2021.","Homo sapiens isolate 368.22.28.GC.1B08.HC immunoglobulin variable region heavy chain mRNA, partial cds",NaN,2022-03-14
30,368.07.GC.28.1A12.HC,NaN,MZ292481,NaN,SARS-CoV-2,Homo sapiens (human),EVQLVESGGGLVQPGRSLRLSCTASGFTFGDYAMNWVRQAPGKGLEWVGFIRSKPYGGTTQYAASVKGRFTISRDDSKSIAYLQMNSLKTEDTAVYYCTRVKYCSGGSCYGYHFDHWGQGTLVTVSS,NaN,"Turner,J.S. et al.; SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses; Nature 596 (7870), 109-113 (2021); 2021.","Homo sapiens isolate 368.07.GC.28.1A12.HC immunoglobulin variable region heavy chain mRNA, partial cds",NaN,2022-03-14
31,NaN,368.20.28.GC.3C08.LC,NaN,MW926430,SARS-CoV-2,Homo sapiens (human),NaN,SVTSYELTQPPSVSMSPGQTARITCSGDALPKKYAYWYQQKSGQAPVLVIYEDSKRPSGIPERFSGSSSGTMATLTISGAQVEDEADYYCYSTDSGGNPQGVFGGGTKLTVL,"Turner,J.S. et al.; SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses; Nature 596 (7870), 109-113 (2021); 2021.",NaN,"Homo sapiens isolate 368.20.28.GC.3C08.LC immunoglobulin variable region light chain mRNA, partial cds",2022-03-14
32,NaN,368.22.28.GC.1B08.LC,NaN,MW926432,SARS-CoV-2,Homo sapiens (human),NaN,EIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQHKPGQAPRLIIYNASNRATGIPARFSGSRSGTDFTLTISSLEPEDFAVYYCQQRSNRPPRWTFGQGTKVEIK,"Turner,J.S. et al.; SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses; Nature 596 (7870), 109-113 (2021); 2021.",NaN,"Homo sapiens isolate 368.22.28.GC.1B08.LC immunoglobulin variable region light chain mRNA, partial cds",2022-03-14
33,NaN,368.22.28.GC.3A11.LC,NaN,MW926441,SARS-CoV-2,Homo sapiens (human),NaN,SYELTQPPSVSVAPGQTARITCGGNNIGRKSVHWYQQKPGQAPVLVVYDDSDRPSGIPERFSGSNSGNTATLTLSRVEAGDEADYYCQVWDNSSDQPNYVFGTGTKVTVL,"Turner,J.S. et al.; SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses; Nature 596 (7870), 109-113 (2021); 2021.",NaN,"Homo sapiens isolate 368.22.28.GC.3A11.LC immunoglobulin variable region light chain mRNA, partial cds",2022-03-14
34,NaN,368.22.GC.28.3F08.LC,NaN,MZ292510,SARS-CoV-2,Homo sapiens (human),NaN,SYELTQPPSVSVAPGQTARITCGGNNIGSKSVHWYQQKPGQAPVLVVYDDSDRPSGIPERFSGSNSGNTATLTISRVEAGDEADYYCQVWDSSSYHAVFGGGTQLTVL,"Turner,J.S. et al.; SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses; Nature 596 (7870), 109-113 (2021); 2021.",NaN,"Homo sapiens isolate 368.22.GC.28.3F08.LC immunoglobulin variable region light chain mRNA, partial cds",2022-03-14
35,NaN,ANTI-RABIES,NaN,AY172962,not determined,Homo sapiens (human),NaN,MAWTVLLLGLLSHCTGSVTSYVLTQPPSVSVAPGKTARINCGGNNIEYRSVHWYQQKSGQAPVAVIYDNSDRPSGIPERFSGSKSGNTATLTISRVEAGDEADYYCQVWDISSDVVFGGGTKLTVLGQPKAAPSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS*,"Prosniak,M. et al.; Development of a cocktail of recombinant-expressed human rabies virus-neutralizing monoclonal antibodies for postexposure prophylaxis of rabies; J. Infect. Dis. 188 (1), 53-56 (2003); 2003.",NaN,"Homo sapiens anti-rabies SOJB immunoglobulin lambda light chain mRNA, complete cds",2022-03-14
36,NaN,NaN,NaN,JQ837832,not determined,Homo sapiens (human),NaN,MDMRVPAQLLGLLLLWLRRVRCDIQMTQSPSSLSACVGDRVTITCRAGHNITNFLSWYQQKPGKAPTLLIYAVSNLQRGVPSRFSGSGSGAEFTLTISSLQPEDFATYYCQQNYNFSFTFGGGTKVDNKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC*,"Hirayasu,K. et al.; Direct Submission; Submitted (27-MAR-2012) Department of Immunochemistry, Immunology Frontier Research Center, Osaka University, Yamadaoka 3-1, Suita, Osaka 565-0871, Japan; 2012.",NaN,"Homo sapiens immunoglobulin kappa light chain mRNA, complete cds",2022-03-14
37,CV2-75,NaN,MW681758,NaN,SARS-CoV-2,Homo sapiens (human),QVQLQESGPGLVKPSETLSLTCTVSGGSISSYYWSWIRQPPGKGLEWIGYVYYSGSTNYNPSLKSRVTISVDTSKNEFSLKLSSVTAADTAVYYCASSQRPDGNLYYFDYWGQGTLVTVSS,NaN,"Jennewein,M.F. et al.; Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects; Unpublished; 2021.","Homo sapiens isolate CV2-75 immunoglobulin heavy chain variable region mRNA, partial cds",NaN,2022-03-14
38,NaN,DK580821,NaN,DK580821,not determined,Macaca fascicularis (crab-eating macaque),NaN,KLSTNLALTDQDSSGHLLTMKLPAQLLGLLVLWLPGSSGDIVMTQTPLSLPVTPGEPASISCRSSQSLLDSEDGSTFLDWYLQKPGQSPQLLIYEVSNRASGVPDRFSGSGSDTDFTLKISRVEAEDVGVYYCMQALEFPLTFGGGTKVEIKRAVAAPSVFIFPPSEDQVKSGTVSVVCLLNNFYPREASVKWKVDGALKTGNSQESVTEQDSKDNTYSLSSTLTLSSTDYQSHNVYACEVTHQGLSSPVTKSFNRGEC*RGEVPQAPHLLLSPSLTPSHPLASGPFPTGELPLFRSSSSSFTSSSSSSSALIMLILGGELINKVNLCKKKKKK,"Osada,N. et al.; Collection of Macaca fascicularis cDNAs derived from bone marrow, kidney, liver, pancreas, spleen, and thymus; BMC Res Notes 2, 199 (2009); 2008.",NaN,"DK580821 macaque thymus cDNA library QthA Macaca fascicularis cDNA clone QthA-17029 5', mRNA sequence",2022-03-14
39,ADI-56674_HC,NaN,MW457639,NaN,SARS-CoV-2,Homo sapiens (human),QVQLVQSGPTLVKPTQTLTLTCTFSGFSLSTSGVGVGWIRQPPGKALEWLALIYWDDDKRYRSSLKSRLTITKDTSKNQVVLTMTNMDPVDTATYYCAHYNPLYVFDYWGQGTLVTVSS,NaN,"Sakharkar,M. et al.; Prolonged evolution of the human B cell response to SARS-CoV-2 infection; Sci Immunol 6 (56) (2021); 2021.","Homo sapiens clone ADI-56674_HC immunoglobulin heavy chain variable region mRNA, partial cds",NaN,2022-03-14
40,ADI-63420_HC,NaN,MW458926,NaN,SARS-CoV-2,Homo sapiens (human),QVQLVQSGAEVKKPGESLKISCKGFGYSFTNYWIAWVRQMPGKGLEWMGIIYPGDSDTRYSPSFQGQVTMSADKSSTTAYLQWSSLKASDTAMYYCARQRRGVSAPGTHYYYGTEVWGQGTTVTVSS,NaN,"Sakharkar,M. et al.; Prolonged evolution of the human B cell response to SARS-CoV-2 infection; Sci Immunol 6 (56) (2021); 2021.","Homo sapiens clone ADI-63420_HC immunoglobulin heavy chain variable region mRNA, partial cds",NaN,2022-03-14
41,TAU-1109_HC_VDJ,NaN,MW367317,NaN,SARS-CoV-2,Homo sapiens (human),QVQLVQSGPEVKKPGASVKVSCKASGYTFTSYSINWVRQAPGQGLEWMGWISTYNGNTNYAQRLQGRVTMTTDTSTGTAHMELRSLRSDDTAIYYCAREEPLYCSGGSCYEFQHWGQGTLVTVSS,NaN,"Mor,M. et al.; Multi-Clonal SARS-CoV-2 Neutralization by Antibodies Isolated from Severe COVID-19 Convalescent Donors; Unpublished; 2021.","Homo sapiens clone TAU-1109_HC_VDJ anti-SARS-CoV-2 neutralizing immunoglobulin gamma heavy chain variable region mRNA, partial cds",NaN,2022-03-14
42,TAU-2189_HC_VDJ,NaN,MW367319,NaN,SARS-CoV-2,Homo sapiens (human),EVQLLESGGGLVQPGGSLRLFCAASGFTFSSFAMSWVRQAPGKGLEWVSTISGSGGRTYYADSVKGRFTIFRDNSKNTLYLQMNSLRAEDTALYYCAKDMDIVVVITGDAFDIWGQGTMVTVSS,NaN,"Mor,M. et al.; Multi-Clonal SARS-CoV-2 Neutralization by Antibodies Isolated from Severe COVID-19 Convalescent Donors; Unpublished; 2021.","Homo sapiens clone TAU-2189_HC_VDJ anti-SARS-CoV-2 neutralizing immunoglobulin gamma heavy chain variable region mRNA, partial cds",NaN,2022-03-14
43,TAU-1145_HC_VDJ,NaN,MW367321,NaN,SARS-CoV-2,Homo sapiens (human),QLQLQESGPGLVKPSETLSLTCTLSGGAIRSGSYYWGWIRQTPGKGLEWIGSIFHIGNAFYNPSLKSRVTISADKAKNQISLNVRSVTAADTAVYYCVRPNNEHGGFFFDYWGQGILVTVSS,NaN,"Mor,M. et al.; Multi-Clonal SARS-CoV-2 Neutralization by Antibodies Isolated from Severe COVID-19 Convalescent Donors; Unpublished; 2021.","Homo sapiens clone TAU-1145_HC_VDJ anti-SARS-CoV-2 neutralizing immunoglobulin gamma heavy chain variable region mRNA, partial cds",NaN,2022-03-14
44,TAU-2220_HC_VDJ,NaN,MW367323,NaN,SARS-CoV-2,Homo sapiens (human),QVQLVQSGAEVKKPGASVKVSCKASGYTFTNYFIHWVRQAPGQGLEWMGMINPSVGSTTYAQNFQGRVTMTRDTSTSTVYMELSSLRSEDTAIYYCARTHVAQLWEIWYFDIWGRGTLVTVSS,NaN,"Mor,M. et al.; Multi-Clonal SARS-CoV-2 Neutralization by Antibodies Isolated from Severe COVID-19 Convalescent Donors; Unpublished; 2021.","Homo sapiens clone TAU-2220_HC_VDJ anti-SARS-CoV-2 neutralizing immunoglobulin gamma heavy chain variable region mRNA, partial cds",NaN,2022-03-14
45,TAU-2230_HC_VDJ,NaN,MW367325,NaN,SARS-CoV-2,Homo sapiens (human),EVQLLESGGGLVQPGGSLRLSCAASGFTFSSYAMNWVRQAPGKGLEWVSVISGSGGRTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKDLDIVVVITGDAFDIWGQGTMVTVSS,NaN,"Mor,M. et al.; Multi-Clonal SARS-CoV-2 Neutralization by Antibodies Isolated from Severe COVID-19 Convalescent Donors; Unpublished; 2021.","Homo sapiens clone TAU-2230_HC_VDJ anti-SARS-CoV-2 neutralizing immunoglobulin gamma heavy chain variable region mRNA, partial cds",NaN,2022-03-14
46,TAU-2212_HC_VDJ,NaN,MW367327,NaN,SARS-CoV-2,Homo sapiens (human),QVQLVQSGAEVKKPGASVKVSCKASGYTFTGYYMHWVRQAPGQGLEWMGWINPNSGGTNYAQKFQGWVTMTRDTSISTAYMELSRLRSDDTAVYYCARGWATYYDILTGYSLFDYWGQGTLVTVSS,NaN,"Mor,M. et al.; Multi-Clonal SARS-CoV-2 Neutralization by Antibodies Isolated from Severe COVID-19 Convalescent Donors; Unpublished; 2021.","Homo sapiens clone TAU-2212_HC_VDJ anti-SARS-CoV-2 neutralizing immunoglobulin gamma heavy chain variable region mRNA, partial cds",NaN,2022-03-14
47,TAU-2303_HC_VDJ,NaN,MW367329,NaN,SARS-CoV-2,Homo sapiens (human),EVQLVESGGGLVQPGGSLRLSCAASGFTVRSNYMSWVRQAPGKGLEWVSLIYSGGSTYYADSVKGRFIISRDNSKNTLYLQMNSLRAEDTAVYYCARDLAVYGMDVWGQGTTVTVSS,NaN,"Mor,M. et al.; Multi-Clonal SARS-CoV-2 Neutralization by Antibodies Isolated from Severe COVID-19 Convalescent Donors; Unpublished; 2021.","Homo sapiens clone TAU-2303_HC_VDJ anti-SARS-CoV-2 neutralizing immunoglobulin gamma heavy chain variable region mRNA, partial cds",NaN,2022-03-14
48,TAU-2310_HC_VDJ,NaN,MW367331,NaN,SARS-CoV-2,Homo sapiens (human),EVQLLESGGGLVQPGGSLRLSCAASGFTFSNYVMSWVRQAPGKGLEWVSGIGGSGDSTYYADSVKGRFTISRDNSKNTLYLQINSLRAEDTAVYYCAKGAAPYYYYYYGMDVWGQGTTVTVSS,NaN,"Mor,M. et al.; Multi-Clonal SARS-CoV-2 Neutralization by Antibodies Isolated from Severe COVID-19 Convalescent Donors; Unpublished; 2021.","Homo sapiens clone TAU-2310_HC_VDJ anti-SARS-CoV-2 neutralizing immunoglobulin gamma heavy chain variable region mRNA, partial cds",NaN,2022-03-14
49,TAU-1115_HC_VDJ,NaN,MW367333,NaN,SARS-CoV-2,Homo sapiens (human),EVQLVESGGGLVQPGGSLRLSCAASGFTFSNYVMSWVRQAPGKGLEWVSGISGSGGSTYYADSMKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKDLTRDYYDSSGYQTGAFDIWGQGTMVTVSS,NaN,"Mor,M. et al.; Multi-Clonal SARS-CoV-2 Neutralization by Antibodies Isolated from Severe COVID-19 Convalescent Donors; Unpublished; 2021.","Homo sapiens clone TAU-1115_HC_VDJ anti-SARS-CoV-2 neutralizing immunoglobulin gamma heavy chain variable region mRNA, partial cds",NaN,2022-03-14
50,NaN,TAU-1109_LC_VJ,NaN,MW367318,SARS-CoV-2,Homo sapiens (human),NaN,EIVLTQSPARLSLSPGERATLSCRASQSVSSDLAWYQQKPGQAPRLLIYDASHRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRINWPPIFTFGPGTKVDIK,"Mor,M. et al.; Multi-Clonal SARS-CoV-2 Neutralization by Antibodies Isolated from Severe COVID-19 Convalescent Donors; Unpublished; 2021.",NaN,"Homo sapiens clone TAU-1109_LC_VJ anti-SARS-CoV-2 neutralizing immunoglobulin kappa light chain variable region mRNA, partial cds",2022-03-14
51,NaN,TAU-2189_LC_VJ,NaN,MW367320,SARS-CoV-2,Homo sapiens (human),NaN,SYELTQPPSVSVSPGQTARITCSGDALPKQYAYWYQQKPGQAPVLVIYKDSERPSGIPERFSGSSSGTTVTLTISGVQAEDEADYYCQSADSSGTYRVFGTGTKVTVL,"Mor,M. et al.; Multi-Clonal SARS-CoV-2 Neutralization by Antibodies Isolated from Severe COVID-19 Convalescent Donors; Unpublished; 2021.",NaN,"Homo sapiens clone TAU-2189_LC_VJ anti-SARS-CoV-2 neutralizing immunoglobulin lambda light chain variable region mRNA, partial cds",2022-03-14
52,NaN,TAU-1145_LC_VJ,NaN,MW367322,SARS-CoV-2,Homo sapiens (human),NaN,SYELTQPPSLSVAPGKTARISCGGNNIGSRSVHWYQQKPGQAPVVVISYDTDRPSEIPERFSGSKSGNTATLTISRVEAGDEADYYCQVWVSTFDHVVFGGGTKLTVL,"Mor,M. et al.; Multi-Clonal SARS-CoV-2 Neutralization by Antibodies Isolated from Severe COVID-19 Convalescent Donors; Unpublished; 2021.",NaN,"Homo sapiens clone TAU-1145_LC_VJ anti-SARS-CoV-2 neutralizing immunoglobulin lambda light chain variable region mRNA, partial cds",2022-03-14
53,NaN,TAU-2220_LC_VJ,NaN,MW367324,SARS-CoV-2,Homo sapiens (human),NaN,QSVLTQPPSASGTPGQRVTISCSGSTSNIGSNAVNWYQQLPGTAPKLLIYSDNHRPSGVPDRFSGSRSGTSASLAISRLQSEDEADYYCAAWDDSLKGVFGGGTKLTVL,"Mor,M. et al.; Multi-Clonal SARS-CoV-2 Neutralization by Antibodies Isolated from Severe COVID-19 Convalescent Donors; Unpublished; 2021.",NaN,"Homo sapiens clone TAU-2220_LC_VJ anti-SARS-CoV-2 neutralizing immunoglobulin lambda light chain variable region mRNA, partial cds",2022-03-14
54,NaN,TAU-2230_LC_VJ,NaN,MW367326,SARS-CoV-2,Homo sapiens (human),NaN,SYELTQPPSVSVSPGQTARITCSGDALPRHYSYWYQQKPGQAPVLLIYKDSERPSGIPERFSGSSSGTTVTLTISGVQAEDEADYYCQSADSSGTYRVFGIGTKVTVL,"Mor,M. et al.; Multi-Clonal SARS-CoV-2 Neutralization by Antibodies Isolated from Severe COVID-19 Convalescent Donors; Unpublished; 2021.",NaN,"Homo sapiens clone TAU-2230_LC_VJ anti-SARS-CoV-2 neutralizing immunoglobulin lambda light chain variable region mRNA, partial cds",2022-03-14
55,NaN,TAU-2212_LC_VJ,NaN,MW367328,SARS-CoV-2,Homo sapiens (human),NaN,QSVLTQPASVSGSPGQSITISCTGTSSDVGSYNLVSWYQQHPGKAPKLMIYEVSKRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCCSYAGSSTPHVVFGGGTKLTVL,"Mor,M. et al.; Multi-Clonal SARS-CoV-2 Neutralization by Antibodies Isolated from Severe COVID-19 Convalescent Donors; Unpublished; 2021.",NaN,"Homo sapiens clone TAU-2212_LC_VJ anti-SARS-CoV-2 neutralizing immunoglobulin lambda light chain variable region mRNA, partial cds",2022-03-14
56,NaN,TAU-2303_LC_VJ,NaN,MW367330,SARS-CoV-2,Homo sapiens (human),NaN,DIQLTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYGASTLQSGVPSRFSGSGSGTEFKLTISSLQPEDFATYYCQQLNNYPPVTFGQGTRLEIK,"Mor,M. et al.; Multi-Clonal SARS-CoV-2 Neutralization by Antibodies Isolated from Severe COVID-19 Convalescent Donors; Unpublished; 2021.",NaN,"Homo sapiens clone TAU-2303_LC_VJ anti-SARS-CoV-2 neutralizing immunoglobulin kappa light chain variable region mRNA, partial cds",2022-03-14
57,NaN,TAU-2310_LC_VJ,NaN,MW367332,SARS-CoV-2,Homo sapiens (human),NaN,QSALTQPASVSGSPGQSITISCTGTSSDVGGYDYVSWYQQHPGKAPKLMIYEVSDRPSGVSNRFSGSKSGSTASLTISGLQAEDEADYYCSSYTSSSALYVFGTGTKVTVL,"Mor,M. et al.; Multi-Clonal SARS-CoV-2 Neutralization by Antibodies Isolated from Severe COVID-19 Convalescent Donors; Unpublished; 2021.",NaN,"Homo sapiens clone TAU-2310_LC_VJ anti-SARS-CoV-2 neutralizing immunoglobulin lambda light chain variable region mRNA, partial cds",2022-03-14
58,NaN,TAU-1115_LC_VJ,NaN,MW367334,SARS-CoV-2,Homo sapiens (human),NaN,SYELNQPPSVSVAPGQTARITCGGNNIGSKSVHWYQQKPGQAPVLVVYDDSDRPSGIPERFSGSNSGNTATLTISRVEAGDEADYYCQVWGGVFGGGTKLTVL,"Mor,M. et al.; Multi-Clonal SARS-CoV-2 Neutralization by Antibodies Isolated from Severe COVID-19 Convalescent Donors; Unpublished; 2021.",NaN,"Homo sapiens clone TAU-1115_LC_VJ anti-SARS-CoV-2 neutralizing immunoglobulin lambda light chain variable region mRNA, partial cds",2022-03-14
59,COVA1-01,NaN,MT599820,NaN,SARS-CoV-2,Homo sapiens (human),HQHQVEQGPGGVEQSETLFLTCCVSGGFTISSCYKRGGIRQPPRKGEEWAVSSYYSSSTYYTPSLKSRVTISVDKSKNQFSLKMSSVTAADTAVYYCARVSSGYYFTPFDYWGQGTRGHRLF,NaN,"Brouwer,P.J.M. et al.; Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability; Unpublished; 2020.","Homo sapiens isolate COVA1-01 anti-SARS-CoV-2 monoclonal antibody heavy chain variable region mRNA, partial cds",NaN,2022-03-14
60,NaN,COVA3-10,NaN,MT599987,SARS-CoV-2,Homo sapiens (human),NaN,DIVMTQSPDSLAVSLGERATINCKSSQSVLYSSNNKNYLAWYQQKPGQPPKLLIYWASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQYYSTPITFGQGTRLEIK,"Brouwer,P.J.M. et al.; Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability; Unpublished; 2020.",NaN,"Homo sapiens isolate COVA3-10 anti-SARS-CoV-2 monoclonal antibody light chain variable region mRNA, partial cds",2022-03-14
61,ADI-55688,NaN,MW417369,NaN,SARS-CoV,Homo sapiens (human),EVQLVESGGGLVKPGGSLRLSCAASGFTFSSYYMNWVRQAPGKGLEWVSSISSDGYNTYYPDSLKGRFTISRDSAKNSLYLQMNSLRADDTAVYYCARDFSGHTAVAGTGFEYWGQGTLVTVSS,NaN,"Rappazzo,C.G. et al.; Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibody; Science 371 (6531), 823-829 (2021); 2021.","Homo sapiens isolate ADI-55688 immunoglobulin heavy chain variable region gene, partial cds",NaN,2022-03-14
62,ADI-57993,NaN,MW417400,NaN,SARS-CoV,Homo sapiens (human),QVQLVESGGGLVQPGGSLRLSCSASGFDFSRFAMHWVRQAPGKGLEYVSAINLHGDSRYYTDSVRGRFTISRDNSKNTLYLQMSSVRPDDTAFYYCVKDGGYYDSSGPGHWGQGTLVTVSS,NaN,"Rappazzo,C.G. et al.; Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibody; Science 371 (6531), 823-829 (2021); 2021.","Homo sapiens isolate ADI-57993 immunoglobulin heavy chain variable region gene, partial cds",NaN,2022-03-14
63,NaN,ADG-1,NaN,MZ439265,SARS-CoV,Homo sapiens (human),NaN,EIVLTQSPATLSLSPGERATLSCRASENILHYLAWYQQKPGQAPRLVIYDASRRATGIPGRFSGSGAGTDFTLTINSLEPEDFAVYYCQQRANWPQNFGGGTKVEIK,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.",NaN,"Homo sapiens isolate ADG-1 immunoglobulin light chain variable region gene, partial cds",2022-03-14
64,NaN,ADG-2,NaN,MZ439267,SARS-CoV,Homo sapiens (human),NaN,QSVLTQPPSVSGAPGQRITISCTGSSSNIGAGYDVHWYQQLPGTAPKLLIYGSSSRNSGVPDRFSGSKSGTSASLAITGLQAEDEADYYCQSYDSSLSVLYTFGTGTKVTVL,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.",NaN,"Homo sapiens isolate ADG-2 immunoglobulin light chain variable region gene, partial cds",2022-03-14
65,NaN,ADG-3,NaN,MZ439269,SARS-CoV,Homo sapiens (human),NaN,QSVLTQPPSASGTPGQRVTISCSGGSSNIGSNSVNWYQQLPGTAPKLLIYSNSQRPSGVPDRFSGSKSGTSASLAISGLQSEDEADYYCAAWDDSLNTFRYVFGTGTKVTVL,"Wec AZ et al.; Broad neutralization of SARS-related viruses by human monoclonal antibodies; Science 369 (6504), 731-736 (2020); 2021.",NaN,"Homo sapiens isolate ADG-3 immunoglobulin light chain variable region gene, partial cds",2022-03-14
66,RBD-SPECIFIC,NaN,MT784731,NaN,"SARS-CoV-2, Spike protein RBD",Vicugna pacos (alpaca),QVQLVETGGGLVQPGGSLRLSCAASGFTFSSVYMNWVRQAPGKGPEWVSRISPNSGNIGYTDSVKGRFTISRDNAKNTLYLQMNNLKPEDTALYYCAIGLNLSSSSVRGQGTQVTVSS,NaN,"Hanke,L. et al.; An alpaca nanobody neutralizes SARS-CoV-2 by blocking receptor interaction; Nat Commun 11 (1) (2020) In press; 2020.","Vicugna pacos SARS-CoV-2 RBD-specific neutralizing immunoglobulin heavy chain mRNA, partial cds",NaN,2022-03-14
67,NaN,ANTI-LIPOPOLYSACCHARIDE,NaN,E10414,not determined,Homo sapiens (human),NaN,QSALTQPASVSGSPGQSITISCTGTSSDVGGYNYVSWYQQHPDTAPKLLIYDVSNRPSGVSTRFSGSKSGNTASLTISGLQAEDEAEYYCSSHAITSTLIFGGGTKLTVLG,"Bizen,F. et al.; GENE CODING HUMAN ANTIBODY CONTAINING B TYPE PSEUDOMONAS AERUGINOS AS ANTIGEN; JP1995327677-A 2 19-DEC-1995 MITSUI TOATSU CHEM INC; 1997.",NaN,cDNA encoding the variable region of lambda chain of human anti-Lipopolysaccharide of Pseudomonas sp,2022-03-14
68,NaN,1-1,NaN,AF334738,not determined,Sus scrofa (pig),NaN,AIVLTQSPLSLSVSPGEPASISCRSSHSLEIYGSNLLSWYQQKPGQSPRLLIYFATNKASGVPDRFSGSGSGTDFTLKISRVEAEDAGVYYCQQHKESLVFGSGTKLEIK,"Perez,C.J. et al.; Direct Submission; Submitted (10-JAN-2001) Immunology Unit, School of Veterinary Sciences, University of Buenos Aires, Chorroarin 280, Capital Federal, Buenos Aires 1427, Argentina; 2002.",NaN,"Sus scrofa clone 1-1 immunoglobulin kappa light chain VJ region mRNA, partial cds",2022-03-14
69,NaN,G502,NaN,AF334742,not determined,Sus scrofa (pig),NaN,AIVLTQTPLSLSVSPGEPASISCRSSQSLLHTTGKNYLNWYLQKPGQSPQRLIYQATNRDTGVPDRFTGSGSGTDFTLKISRVEAEDAGVYYCLQFKESPPGFGAGTKLELK,"Perez,C.J. et al.; Direct Submission; Submitted (10-JAN-2001) Immunology Unit, School of Veterinary Sciences, University of Buenos Aires, Chorroarin 280, Capital Federal, Buenos Aires 1427, Argentina; 2002.",NaN,"Sus scrofa clone G502 immunoglobulin kappa light chain VJ region mRNA, partial cds",2022-03-14
70,NB21,NaN,KX278382,NaN,MERS-CoV,Camelus dromedarius (Arabian camel),QVQLQESGGGSVQTGGSLRLSCAASGSVYCMGWIRQAPGKEREGVARINSDGSVTYYGSSAKGRFSISRDSAKNTVTLLMNSLKPEDTAIYTCTAGTRKCMDLGSWIDFDYRGQGTQVTVSS,NaN,"Stalin Raj,V. et al.; Rapid identification of nanobodies by direct cloning from a bone marrow cDNA library; Unpublished; 2020.","Camelus dromedarius clone nb21 anti-MERS-CoV immunoglobulin heavy chain VHDJ region (IgVH) mRNA, partial cds",NaN,2022-03-14
71,NBP2E6,NaN,KX278416,NaN,MERS-CoV,Camelus dromedarius (Arabian camel),QVQLQESGGGSVQAGGSLRLSCAASWHTYSSNCLGWFRQAPGKERDLVAALYINGGSTYYADSVKGRFAISQDSARNSVYLQMNSLKPEDTAMYYCAADDPALDDLSSGGYCSRAYGYHYWGQGTQVTVSS,NaN,"Stalin Raj,V. et al.; Rapid identification of nanobodies by direct cloning from a bone marrow cDNA library; Unpublished; 2020.","Camelus dromedarius clone nbp2E6 anti-MERS-CoV immunoglobulin heavy chain VHDJ region (IgVH) mRNA, partial cds",NaN,2022-03-14
72,NaN,NaN,NaN,JN093123,not determined,Homo sapiens (human),NaN,EIVLTQSPGTLSLSPGERATLSCRASQSVSMNYLAWFQQKPGQAPRLLIYGASRRATGIPDRISGSGSGTDFTLTISRLEPADFAVYYCQQYGTSPRT,"Ekiert,D.C. et al.; A highly conserved neutralizing epitope on group 2 influenza A viruses; Science 333 (6044), 843-850 (2011); 2011.",NaN,"Homo sapiens immunoglobulin light chain variable region mRNA, complete cds",2022-03-14
73,4A8,NaN,MT622682,NaN,not determined,Homo sapiens (human),MNFGLSLIFLVLILKGVQCEVQLVESGAEVKKPGASVKVSCKVSGYTLTELSMHWVRQAPGKGLEWMGGFDPEDGETMYAQKFQGRVTMTEDTSTDTAYMELSSLRSEDTAVYYCATSTAVAGTPDLFDYYYGMDVWGQGTTVTVSS,NaN,"Chen,W. et al.; Direct Submission; Submitted (12-JUN-2020) Vaccine and Antibody, Beijing Insititute of Biotechonology, Dongdajie Street, Beijing, MB 100071, China; 2020.","Homo sapiens clone 4A8 immunoglobulin heavy chain variable region gene, partial cds",NaN,2022-03-14
